Reyataz and Deafness transitory partial - from FDA reports


Summary

There is no Deafness transitory partial reported by people who take Reyataz yet. This review analyzes which people have Deafness transitory partial with Reyataz. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Reyataz and have Deafness transitory partial, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 14, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Deafness transitory partial when taking Reyataz?

Expand the study to include all drugs with the same ingredients

Deafness transitory partial and drugs with ingredients of atazanavir sulfate.

Expand the study to include reports from both FDA and eHealthMe

Deafness transitory partial and Reyataz from FDA and eHealthMe reports

Reyataz

Reyataz has active ingredients of atazanavir sulfate. It is often used in hiv infection. (latest outcomes from Reyataz 8,724 users)

Deafness Transitory Partial

Deafness transitory partial (deafness temporary-partial) (latest reports from 3 Deafness transitory partial patients).

Browse all side effects of Reyataz

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Deafness transitory partial

Deafness transitory partial

Could your condition cause Deafness transitory partial

Deafness transitory partial

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Reyataz and have Deafness transitory partial.

User reviews to the study

More reviews >